Literature DB >> 15864135

Functional characterization of a novel polymorphism of pregnane X receptor, Q158K, in Chinese subjects.

Yun-Ping Lim1, Chin-Hung Liu, Lih-Jen Shyu, Jin-Ding Huang.   

Abstract

The pregnane X receptor (PXR) is the main transcriptional regulator of many enzymes that metabolize xenobiotics such as P450s and drug transporters. Polymorphisms in the PXR gene contribute to population variability in CYP3A4 and P-glycoprotein levels. Single nucleotide polymorphisms (SNPs) have been reported in Caucasian, African-American and Japanese populations. In the present study, we identified the known SNP, V140M and a novel SNP, Q158K, in Chinese subjects. We developed an allele-specific polymerase chain reaction method to detect the novel allele and found its frequency in 451 Chinese subjects to be 2.2%. CYP3A4-luciferase reporter assays revealed that the Q158K variant gave rise to much lower levels of CYP3A4 promoter activity in LS174T and HepG2 cells exposed to the PXR ligands, rifampin and paclitaxel, than did wild-type PXR. The SNP had less effect on promoter activity in response to clotrimazole or nifedipine.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15864135     DOI: 10.1097/01213011-200505000-00009

Source DB:  PubMed          Journal:  Pharmacogenet Genomics        ISSN: 1744-6872            Impact factor:   2.089


  13 in total

1.  CYP3A phenotypes and genotypes in North Indians.

Authors:  Naushad Rais; Yogesh K Chawla; Krishan K Kohli
Journal:  Eur J Clin Pharmacol       Date:  2006-04-21       Impact factor: 2.953

2.  Activation of CAR and PXR by Dietary, Environmental and Occupational Chemicals Alters Drug Metabolism, Intermediary Metabolism, and Cell Proliferation.

Authors:  J P Hernandez; L C Mota; W S Baldwin
Journal:  Curr Pharmacogenomics Person Med       Date:  2009-06-01

3.  Nonylphenol-mediated CYP induction is PXR-dependent: The use of humanized mice and human hepatocytes suggests that hPXR is less sensitive than mouse PXR to nonylphenol treatment.

Authors:  Linda C Mota; Christina Barfield; Juan P Hernandez; William S Baldwin
Journal:  Toxicol Appl Pharmacol       Date:  2011-03-02       Impact factor: 4.219

4.  PXR polymorphisms and their impact on pharmacokinetics/pharmacodynamics of repaglinide in healthy Chinese volunteers.

Authors:  Qing-qing Du; Zhi-jun Wang; Lin He; Xue-hua Jiang; Ling Wang
Journal:  Eur J Clin Pharmacol       Date:  2013-06-27       Impact factor: 2.953

5.  Comparative genomics of xenobiotic metabolism: a porcine-human PXR gene comparison.

Authors:  Callie B Pollock; Margarita B Rogatcheva; Lawrence B Schook
Journal:  Mamm Genome       Date:  2007-04-15       Impact factor: 2.957

6.  Photochemotherapeutic agent 8-methoxypsoralen induces cytochrome P450 3A4 and carboxylesterase HCE2: evidence on an involvement of the pregnane X receptor.

Authors:  Jian Yang; Bingfang Yan
Journal:  Toxicol Sci       Date:  2006-09-26       Impact factor: 4.849

7.  Impact of the haplotypes of the human pregnane X receptor gene on the basal and St John's wort-induced activity of cytochrome P450 3A4 enzyme.

Authors:  Xue-Ding Wang; Jia-Li Li; Qi-Biao Su; Su Guan; Jie Chen; Jun Du; Yu-Wen He; Jun Zeng; Jin-Xin Zhang; Xiao Chen; Min Huang; Shu-Feng Zhou
Journal:  Br J Clin Pharmacol       Date:  2008-12-01       Impact factor: 4.335

Review 8.  PXR: a xenobiotic receptor of diverse function implicated in pharmacogenetics.

Authors:  Bin Zhang; Wen Xie; Matthew D Krasowski
Journal:  Pharmacogenomics       Date:  2008-11       Impact factor: 2.533

Review 9.  Role of pregnane X receptor in chemotherapeutic treatment.

Authors:  Wei Zhuo; Lei Hu; Jinfeng Lv; Hongbing Wang; Honghao Zhou; Lan Fan
Journal:  Cancer Chemother Pharmacol       Date:  2014-06-03       Impact factor: 3.333

10.  Top Three Pharmacogenomics and Personalized Medicine Applications at the Nexus of Renal Pathophysiology and Cardiovascular Medicine.

Authors:  Murielle Bochud; Michel Burnier; Idris Guessous
Journal:  Curr Pharmacogenomics Person Med       Date:  2011-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.